Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$204.81 - $262.19 $2.71 Million - $3.48 Million
-13,256 Reduced 44.98%
16,217 $3.32 Million
Q2 2022

Aug 09, 2022

BUY
$213.86 - $277.87 $692,692 - $900,020
3,239 Added 12.35%
29,473 $6.91 Million
Q1 2022

May 18, 2022

SELL
$259.82 - $298.18 $1.58 Million - $1.81 Million
-6,074 Reduced 18.8%
26,234 $6.92 Million
Q4 2021

Jan 28, 2022

BUY
$271.6 - $314.21 $253,402 - $293,157
933 Added 2.97%
32,308 $10.2 Million
Q3 2021

Oct 14, 2021

BUY
$274.82 - $308.34 $768,121 - $861,810
2,795 Added 9.78%
31,375 $8.83 Million
Q2 2021

Aug 10, 2021

SELL
$251.87 - $278.14 $239,024 - $263,954
-949 Reduced 3.21%
28,580 $7.88 Million
Q1 2021

May 10, 2021

BUY
$204.88 - $255.03 $6.05 Million - $7.53 Million
29,529 New
29,529 $7.53 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Financial Enhancement Group LLC Portfolio

Follow Financial Enhancement Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.